A detailed history of Cypress Point Wealth Management, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Cypress Point Wealth Management, LLC holds 412 shares of LLY stock, worth $353,277. This represents 0.18% of its overall portfolio holdings.

Number of Shares
412
Holding current value
$353,277
% of portfolio
0.18%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 07, 2024

BUY
$592.2 - $792.28 $243,986 - $326,419
412 New
412 $320,000
Q4 2021

Jan 27, 2022

SELL
$224.85 - $279.04 $76,449 - $94,873
-340 Closed
0 $0
Q2 2021

Aug 04, 2021

BUY
$180.55 - $233.54 $61,387 - $79,403
340 New
340 $78,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $815B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Cypress Point Wealth Management, LLC Portfolio

Follow Cypress Point Wealth Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cypress Point Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cypress Point Wealth Management, LLC with notifications on news.